Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway.
Lammas
D A
DA
MRC Centre for Immune Regulation, The Medical School and Regional Department of Immunology, Heartlands Hospital, Birmingham, UK.
Casanova
J L
JL
Kumararatne
D S
DS
D000818:Animals; D001424:Bacterial Infections / Q000209:etiology / Q000235:genetics / Q000276:immunology; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000209:etiology / Q000235:genetics / Q000276:immunology; D007371:Interferon-gamma / Q000235:genetics* / Q000502:physiology*; D018664:Interleukin-12 / Q000172:deficiency / Q000235:genetics / Q000502:physiology*; D011379:Prognosis; D017471:Receptors, Interferon / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D018123:Receptors, Interleukin / Q000172:deficiency / Q000235:genetics / Q000502:physiology; D053707:Receptors, Interleukin-12; D015398:Signal Transduction; D018417:Th1 Cells / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology; D000096743:Interferon gamma Receptor
D007371:Interferon-gamma; D018664:Interleukin-12; D017471:Receptors, Interferon; D018123:Receptors, Interleukin; D053707:Receptors, Interleukin-12; D000096743:Interferon gamma Receptor